| ［1］ Ganzel C, Becker J, Mintz PD, et al. Hyperleukocytosis, leukostasis and leukapheresis: practice management［J］. Blood Rev, 2012, 26(3): 117-122. ［2］ Belák M, Jákó J. Indications of urgent plasma exchange and cytapheresis therapiesa review based on literature data and personal experience［J］. Orv Hetil, 2006, 147(38): 1843-1848. ［3］ 张之南, 沈悌. 血液病诊断及疗效标准［M］. 北京: 科学出版社, 2007: 130. ［4］ Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practiceevidencebased approach from the Apheresis Applications Committee of the American Society for Apheresis［J］. J Clin Apher, 2010, 25(3): 83-177. ［5］ 王冠宙, 胡治黄, 王红娟. 急性高白细胞白血病31例疗效分析［J］. 实用医学杂志, 2013, 20(3): 301-303. ［6］ 王敏, 王立茹. 高白细胞白血病研究现状［J］. 中国实用内科杂志, 2011, 31(4): 298-300. ［7］ 孙黎飞, 马旭辉, 许刚, 等. 白细单采联合化学药物治疗高白细胞性白血病［J］. 实用医药杂志, 2008, 25(9): 1059. ［8］ Chang MC, Chen TY, Tang JL, et al. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage［J］. Am J Hematol, 2007, 82(11): 976-980. |
